Results 241 to 250 of about 700,247 (353)

Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation? [PDF]

J Cardiovasc Dev Dis
Laviola D, Manzi G, Recchioni T, Luise MC, Mercurio V, Mihai A, Badagliacca R, Papa S, Vizza CD.   +8 more
europepmc   +1 more source

REPEAT CATHETERIZATION IN VENTRICULAR SEPTAL DEFECT AND PULMONARY HYPERTENSION

, 1962
G. Howitt, E. G. Wade
openalex   +1 more source

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT‐ACS Emulation Using National Health Insurance Claims Data

Clinical Pharmacology &Therapeutics, EarlyView.
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li   +6 more
wiley   +1 more source

Breathing Under Pressure? Air Pollution and Mortality in Pulmonary Hypertension. [PDF]

Ann Am Thorac Soc
Synn AJ, Nassikas NJ.
europepmc   +1 more source

Masked Infundibular Pulmonary Obstruction in Ventricular Septal Defect with Pulmonary Hypertension

, 1965
John H.K. Vogel, S.Gilbert Blount
openalex   +1 more source

Pulmonary Hypertension and Mortality in Patients Awaiting Kidney Transplant: Cause for Concern and Potential Opportunity. [PDF]

, 2020
Bokoch, Michael P, Findlay, James Y
core   +1 more source

Expediting Drug Development in Japan: A PMDA Perspective

Clinical Pharmacology &Therapeutics, EarlyView.
Review time for a new drug in Japan has shortened dramatically since the establishment of the Pharmaceuticals and Medical Devices Agency (PMDA). Nonetheless, Japan faces a new challenge so‐called “Drug Loss”, which means that new drugs approved overseas have not yet been developed in Japan or that development is delayed. In this manuscript, we describe
Yoichi Kohno, Akihiro Ishiguro, Takashi Yasukawa, Naoyuki Yasuda, Daisuke Tanaka, Yasuhiro Araki, Yukio Takahashi, Yoshiaki Uyama, Yasuhiro Fujiwara   +8 more
wiley   +1 more source

Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real‐World Data Utilization

Clinical Pharmacology &Therapeutics, EarlyView.
Clinical trials with pragmatic elements can capture diverse patient populations, enable efficient follow‐up, and reflect routine clinical practices; yet there is limited understanding of their design features, characteristics, and use of real‐world data (RWD). Based on a targeted search of PubMed/EMBASE (Jan‐2016 to Jul‐2024), a review was conducted to
Le Su, Lei Chen, Seema Betigeri, Nancy Dreyer, Helga Gardarsdottir, Rachele Hendricks‐Sturrup, Mehmet Burcu   +6 more
wiley   +1 more source

Pulmonary arterial hypertension exacerbated by ruxolitinib

Haematologica, 2015
Andrew T. Low, Luke Howard, Claire Harrison, Robert M.R. Tulloh   +3 more
doaj   +1 more source

Uncommon Cause of Pulmonary Hypertension: Imaging Diagnosis of Cardiac Myxoma Embolism. [PDF]

Diagnostics (Basel)
Braillon A, Patural P, Laville D, Perros F, Turquier S, Cottin V, L'Huillier R, Si-Mohamed S.   +7 more
europepmc   +1 more source